- Study provides insight into link between two rare tumor syndromes
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation can also cause a benign tumor condition in humans in adulthood.
August 21, 2017 6:00 AMdetail
- How prostate cancer patients can choose a treatment they won’t regret
A study published in the Journal of Clinical Oncology in July suggests that as many as 15 percent of patients who undergo treatment for prostate cancer later regret the treatment they choose. Dr. Christopher Saigal, vice chair of urology at UCLA, is trying to fix that.
August 18, 2017 10:00 AMdetail
- Protecting kids against HPV before cancer risk increases
Some parents remain hesitant to get their children vaccinated for the human papilloma virus, despite assurances by medical experts that the recommended shots are both highly safe and effective.
August 15, 2017 10:00 AMdetail
- Findings pave way for three-drug combination treatment for childhood leukemia
UCLA researchers have developed a new approach that could eventually help young people respond better to treatment for acute lymphoblastic leukemia. The scientists discovered in mice that when the production of nucleotides is stopped, a “DNA replication stress response” is activated. The replication stress response is a cellular monitoring system that usually senses and resolves DNA damage, but instead allows cancer cells to survive.
August 14, 2017 6:00 AMdetail
- Michael Teitell named director of the UCLA Jonsson Comprehensive Cancer Center
Dr. Michael Teitell, a renowned molecular immunologist and biochemist, has been named director of the UCLA Jonsson Comprehensive Cancer Center and president of the Jonsson Cancer Center Foundation.
August 10, 2017 12:00 PMdetail
- Study offers road map to personalized therapies for sarcoma and other aggressive cancers
Sarcoma is a rare and deadly form of cancer occurring in the bones and connective tissue that affects individuals of all ages. Its aggressiveness, rarity and diversity continue to hinder efforts to identify effective therapies for people with this malignancy. Patient-derived orthotopic xenografts (PDOX) are unique models where a patient’s individual tumor is grown in mice. Such xenografts have long shown great promise in modeling how sarcoma and other cancers can respond to and resist therapies, but their feasibility for use in individual patients in clinical settings remains unknown.
August 04, 2017 1:00 PMdetail
- World Lung Cancer Day 2017
In honor of World Lung Cancer Day, UCLA Jonsson Comprehensive Cancer Center researcher Dr. Edward Garon provides an update on the current state of lung cancer research and treatments.
August 01, 2017 6:00 AMdetail
- UCLA scientist awarded prestigious grant to identify the drivers of prostate cancer metastasis
Dr. Nicholas G. Nickols, an attending physician at the West LA VA and assistant professor of radiation oncology at the David School of Medicine, has been awarded the prestigious 2017 VALOR Young Investigator Award by the Prostate Cancer Foundation.
July 19, 2017 6:00 AMdetail
- Renowned UCLA researcher assumes editorial leadership of prestigious cancer journal
As of July 1, 2017 Dr. Patricia Ganz will assume editorial leadership of one of the oldest and most internationally respected oncology journals, JNCI: Journal of the National Cancer Institute.
July 05, 2017 9:00 AMdetail
- Prostate cancer diagnosis and treatment have evolved. Here’s where we are.
Dr. Mark Litwin discusses his new review of the diagnosis and treatment of prostate cancer in JAMA, and how he assesses the optimal methods for the diagnosis and treatment of prostate cancer based on current evidence.
July 03, 2017 10:00 AMdetail
- Grill out cancer
Did you know grilling can increase your risk for cancer? Don't worry, our own Dr. Catherine Carpenter, professor of clinical nutrition, has some healthy tips to keep your summer barbecue lit!
June 30, 2017 1:00 PMdetail
- People making a difference: UCLA's Sheila Henry
Cancer survivor Sheila Henry spent 18 years raising money for cancer research at the Jonsson Cancer Center Foundation at UCLA and UCLA Health. Watch her story on KCAL 9 and CBS Los Angeles.
June 29, 2017 12:00 PMdetail
- Renowned UCLA physician-scientist to receive highest honor for advancing the science and practice of radiation oncology
Dr. Michael Steinberg, Director of Clinical Affairs at UCLA’s Jonsson Comprehensive Cancer Center, and professor and chair of the Department of Radiation Oncology at the David Geffen School of Medicine, has received the American Society for Radiation Oncology (ASTRO) 2017 Gold Medal for his outstanding lifetime contributions in the field of radiation oncology.
June 27, 2017 10:00 AMdetail
- UCLA scientist awarded grant to study childhood cancer in Taiwan
A non-profit organization focused on raising money for childhood cancer research has awarded Dr. Julia Heck, associate research professor of epidemiology in the UCLA Fielding School of Public Health, with a two-year, $200,000 grant to study pediatric cancer in Taiwan.
June 14, 2017 8:00 AMdetail
- Lila and the mountain
After her second diagnosis with cancer, Lila Javan had to put her dream of climbing Mt. Kilimanjaro on hold. But that didn't stop her from eventually reaching the peak, and this time she was able to bring along a special group of friends including her oncologist, UCLA's Dr. Sarah Larson.
June 04, 2017 6:00 AMdetail
- UCLA Jonsson Comprehensive Cancer Center scientists to present on latest cancer research advancements at ASCO 2017
Scientists with UCLA’s Jonsson Comprehensive Cancer Center will present some of the most highly anticipated research at the 2017 Annual Meeting of the American Society of Clinical Oncology (ASCO). The event takes place at the McCormick Convention Center in Chicago from June 2 through June 6.
June 01, 2017 9:00 AMdetail
- Radiation therapy can enhance effectiveness of immunotherapy in people with advanced lung cancer, UCLA study finds
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
May 25, 2017 6:30 AMdetail
- Tai chi relieves insomnia in breast cancer survivors
If you have had insomnia, you know worrying about sleep makes it even harder to fall asleep. For the 30 percent of breast cancer survivors who have insomnia, sleepless nights can lead to depression, fatigue and a heightened risk of disease.
May 15, 2017 9:00 AMdetail
- Dendritic cell vaccine augments the immune system in people with non-small cell lung cancer
UCLA scientists have discovered a dendritic cell vaccine that amplifies the response of the immune system in people with non-small cell lung cancer, the most common form of lung cancer.
May 11, 2017 9:00 AMdetail
- Yael & Scooter Braun honored at UCLA Jonsson Cancer Center's Taste for a Cure 2017 James Corden
Celebrating its 22nd year, the UCLA Jonsson Cancer Center Foundation’s signature event, Taste for a Cure, was held on Friday, April 28 at the Beverly Wilshire Hotel. During this special evening, Yael and Scooter Braun were honored with the 2017 Gil Nickel Humanitarian Award, presented by James Corden.
May 09, 2017 10:00 AMdetail